New Jersey Jury Ordered Roche to Pay $18M to Two Former Accutane Users

Earlier this year a New Jersey jury orders Roche Holding AG (ROG) to pay $18 million in product liability and personal injury damages to two former users of Accutane in a verdict on Accutane inflammatory bowel disease trial. Roche is the developer and manufacturer of Accutane, a drug intended for treatment of acne.

The plaintiffs blamed Accutane acne drug for the inflammatory bowel disease (IBD) they have contracted. Jurors discovered that the drug giant failed to properly warn the plaintiffs that the medication could cause users to develop inflammatory bowel disease.

Experts say that there were about 16 million who took Roche’s second biggest-selling drug Accutane for acne treatment since it came out in 1982. In 2009, Roche withdrew Accutane’s brand name version off the market after juries started awarding large amounts of damages over IBD claims. The verdicts were handed down about a week after European regulators confirmed that the drug company systematically failed to evaluate safety issue reports involving its drugs to determine if the drugs should be forwarded to health authorities. The regulators also discovered about 80,000 reports that involved U.S.-marketed drugs which have not undergone evaluation to determine whether they need to be passed on to EU as drugs capable of creating adverse reactions to users.

Roche had already lost 9 out of the 13 lawsuits filed by former Accutane acne drug users that have started going to trial since 2007. Roche and the manufacturers of the controversial drug’s generic versions  faced almost 8,000 lawsuits in New Jersey state court. The litigation had been centralized as part of a mass tort. All personal injury claims brought by Accutane users involve severe inflammatory bowel disease, Crohn’s disease and ulcerative colitis.

Thousands of Americans are believed to be affected by faulty pharmaceutical products each year. In cases such as these, the pharmaceutical company may be held liable for the injuries resulting from the use of faulty drugs.

A drug can be considered faulty if it is contaminated, fails to deliver what it promised or causes unforeseen side effects resulting to development of other diseases or injuries for individuals taking the drug. If you have developed diseases or injuries by taking faulty drugs, you are entitled to receive financial compensation. An experienced medical malpractice attorney or New Jersey product liability attorney will help you with your case.

Leave a Reply

Your email address will not be published. Required fields are marked *